Skip to main content

Advertisement

SpringerLink
Log in

Relative cerebral blood volume from dynamic susceptibility contrast perfusion in the grading of pediatric primary brain tumors

  • Paediatric Neuroradiology
  • Published:
Neuroradiology Aims and scope Submit manuscript

Abstract

Introduction

The aim of this study is to evaluate the utility of relative cerebral blood volume (rCBV) data from dynamic susceptibility contrast (DSC) perfusion in grading pediatric primary brain tumors.

Methods

A retrospective blinded review of 63 pediatric brain tumors with DSC perfusion was performed independently by two neuroradiologists. A diagnosis of low- versus high-grade tumor was obtained from conventional imaging alone. Maximum rCBV (rCBVmax) was measured from manual ROI placement for each reviewer and averaged. Whole-tumor CBV data was obtained from a semi-automated approach. Results from all three analyses were compared to WHO grade.

Results

Based on conventional MRI, the two reviewers had a concordance rate of 81 % (k = 0.62). Compared to WHO grade, the concordant cases accurately diagnosed high versus low grade in 82 %. A positive correlation was demonstrated between manual rCBVmax and tumor grade (r = 0.30, P = 0.015). ROC analysis of rCBVmax (area under curve 0.65, 0.52–0.77, P = 0.03) gave a low-high threshold of 1.38 with sensitivity of 92 % (74–99 %), specificity of 40 % (24–57 %), NPV of 88 % (62–98 %), and PPV of 50 % (35–65 %) Using this threshold on 12 discordant tumors between evaluators from conventional imaging yielded correct diagnoses in nine patients. Semi-automated analysis demonstrated statistically significant differences between low- and high-grade tumors for multiple metrics including average rCBV (P = 0.027).

Conclusions

Despite significant positive correlation with tumor grade, rCBV from pediatric brain tumors demonstrates limited specificity, but high NPV in excluding high-grade neoplasms. In selective patients whose conventional imaging is nonspecific, an rCBV threshold may have further diagnostic value.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Law M, Yang S, Wang H et al (2003) Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24:1989–1998

    PubMed  Google Scholar 

  2. Bulakbasi N, Kocaoglu M, Farzaliyev A et al (2005) Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors. AJNR Am J Neuroradiol 26:2187–2199

    PubMed  Google Scholar 

  3. Law M, Young R, Babb J et al (2007) Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. AJNR Am J Neuroradiol 28:761–766

    CAS  PubMed  Google Scholar 

  4. Shin J, Lee H, Kwun B et al (2002) Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. Am J Roentgenol 179:783–789

    Article  Google Scholar 

  5. Law M, Young R, Babb J et al (2006) Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 27:1975–1982

    CAS  PubMed  Google Scholar 

  6. Fan G, Deng Q, Wu Z, Guo Q (2006) Usefulness of diffusion/perfusion-weighted MRI in patients with non-enhancing supratentorial brain gliomas: a valuable tool to predict tumour grading? Br J Radiol 79:652–658

    Article  CAS  PubMed  Google Scholar 

  7. Morita N, Wang S, Chawla S et al (2010) Dynamic susceptibility contrast perfusion weighted imaging in grading of nonenhancing astrocytomas. J Magn Reson Imaging 32(4):803–808

    Article  PubMed  Google Scholar 

  8. Boxerman J, Schmainda K, Weisskoff R (2006) Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 27:859–67

    CAS  PubMed  Google Scholar 

  9. Ball W Jr, Holland S (2001) Perfusion imaging in the pediatric patient. Magn Reson Imaging Clin N Am 9:207–230

    PubMed  Google Scholar 

  10. Yeom K, Mitchell L, Lober R et al (2014) Arterial spin-labeled perfusion of pediatric brain tumors. AJNR Am J Neuroradiol 35(2):395–401. doi:10.3174/ajnr.A3670

    Article  CAS  PubMed  Google Scholar 

  11. Koeller K, Rushing E (2004) From the archives of the AFIP: pilocytic astrocytoma: radiologic-pathologic correlation. Radiographics 24:1693–1708

    Article  PubMed  Google Scholar 

  12. Brat D, Scheithauer B, Fuller G, Tihan T (2007) Newly codified glial neoplasms of the 2007 WHO classification of tumours of the central nervous system: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma. Brain Pathol 17:319–324

    Article  PubMed  Google Scholar 

  13. Lev M, Ozsunar Y, Henson J et al (2004) Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. AJNR Am J Neuroradiol 25:214–221

    PubMed  Google Scholar 

  14. Xu M, See S, Ng W et al (2005) Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors. Neurosurgery 56:919–926

    PubMed  Google Scholar 

  15. Kool M, Korshunov A, Remke M et al (2012) Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, group 3, and group 4 medulloblastomas. Acta Neuropathol 123(4):473–84. doi:10.1007/s00401-012-0958-8

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Cha S (2006) Dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in pediatric patients. Neuroimaging Clin N Am 16(1):137–147

    Article  PubMed  Google Scholar 

  17. Grand S, Kremer S, Tropres I et al (2007) Perfusion-sensitive MRI of pilocytic astrocytomas: initial results. Neuroradiology 49(7):545–550

    Article  PubMed  Google Scholar 

  18. Yuh E, Barkovich A, Gupta N (2009) Imaging of ependymomas: MRI and CT. Childs Nerv Syst 25:1203–1213

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Sentürk S, Oğuz K, Cila A (2009) Dynamic contrast enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3 T MR scanner. Diagn Interv Radiol 15:3–12

    PubMed  Google Scholar 

  20. Lev MH, Rosen BR (1999) Clinical applications of intracranial perfusion MR imaging. Neuroimaging Clin N Am 9:309–331

    CAS  PubMed  Google Scholar 

  21. Darpolor MM, Molthen RC, Schmainda KM (2011) Multimodality imaging of abnormal vascular perfusion and morphology in preclinical 9L gliosarcoma model. PLoS One 6(1):e16621

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Quarles CC, Krouwer HG, Rand SD, Schmainda KM (2005) Dexamethasone normalizes brain tumor hemodynamics as indicated by dynamic susceptibility contrast MRI perfusion parameters. Technol Cancer Res Treat 4(3):245–9

    Article  CAS  PubMed  Google Scholar 

  23. Wilkinson ID, Jellineck DA, Levy D et al (2006) Dexamethasone and enhancing solitary cerebral mass lesions: alterations in perfusion and blood-tumor barrier kinetics shown by magnetic resonance imaging. Neurosurgery 58(4):640–6

    Article  PubMed  Google Scholar 

  24. Armitage PA, Schwindack C, Bastin ME, Whittle IR (2007) Quantitative assessment of intracranial tumor response to dexamethasone using diffusion, perfusion and permeability magnetic resonance imaging. Magn Reson Imaging 25(3):303–10

    Article  CAS  PubMed  Google Scholar 

  25. Bastin ME, Carpenter TK, Armitage PA et al (2006) Effects of dexamethasone on cerebral perfusion and water diffusion in patients with high-grade glioma. AJNR Am J Neuroradiol 27(2):402–8

    CAS  PubMed  Google Scholar 

Download references

Ethical standards and patient consent

We declare that this manuscript does not contain clinical studies or identifiable patient data, and therefore, the Institutional Review Board of Indiana University waived consent.

Conflict of interest

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Radiology, MRI Department, Indiana University School of Medicine, 705 Riley Hospital Drive, Indianapolis, IN, 46202, USA

    Chang Y. Ho, Jeremy S. Cardinal, Aaron P. Kamer & Stephen F. Kralik

Authors
  1. Chang Y. Ho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeremy S. Cardinal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aaron P. Kamer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stephen F. Kralik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chang Y. Ho.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ho, C.Y., Cardinal, J.S., Kamer, A.P. et al. Relative cerebral blood volume from dynamic susceptibility contrast perfusion in the grading of pediatric primary brain tumors. Neuroradiology 57, 299–306 (2015). https://doi.org/10.1007/s00234-014-1478-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00234-014-1478-0

Keywords

Search

Navigation